Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-04-22

FDA Approved: ALVESCO — Supplemental Application (Covis Pharma US, Inc)

View source ↗

Summary

FDA approved a supplemental application for ALVESCO (ciclesonide) submitted by Covis Pharma US, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alvesco (ciclesonide)

Snippet

SUPPL AP for ALVESCO (CICLESONIDE)